Effects of vitamins C and D in type 2 diabetes mellitus
Authors Christie-David D, Girgis C, Gunton J
Received 24 September 2014
Accepted for publication 26 November 2014
Published 10 February 2015 Volume 2015:7 Pages 21—28
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Chandrika Piyathilake
Darshika J Christie-David,1,2 Christian M Girgis,2–4 Jenny E Gunton1–4
1Department of Endocrinology and Diabetes, Westmead Hospital, 2Faculty of Medicine, University of Sydney, 3Westmead Millennium Institute, 4Garvan Institute of Medical Research, Sydney, NSW, Australia
Abstract: Scurvy and rickets are largely considered historical diseases in developed countries. However, deficiencies in vitamins C and D are re-emerging due to increased consumption of processed foods and reduced fresh foods in the Western diet, as well as to an indoor sedentary lifestyle away from sun exposure. These dietary and lifestyle factors also predispose one to diabetes and metabolic syndrome. Our understanding of the potential roles of vitamin C (an antioxidant) and vitamin D (a biologically active hormone) in disease is increasing. In this review, we present observational, interventional, and mechanistic studies that examine the potential links between vitamins C and D in reversing defects in glucose homeostasis and the prevention of type 2 diabetes. Studies suggest an association between vitamin C deficiency and diabetes. An association between vitamin D and insulin resistance has been well described; however, the role of vitamin C and D supplementation in diabetes and its prevention requires further controlled trials.
Keywords: glucose homeostasis, diabetes, insulin resistance, vitamin C, vitamin D
Nutrients play essential roles in health and the prevention of disease. Nutrients, including vitamins, are vital to cardiovascular health (ie, vitamin B1), nerve function (ie, vitamins B6 and B12), the production of red blood cells (ie, folate and vitamin B12), and coagulation (ie, vitamin K), among many other functions.1 Scurvy and rickets were largely thought to be conditions of historical interest in developed countries; however, deficiency in vitamins C and D are re-emerging due to increasingly inadequate carbohydrate- and fat-based Western diets and sedentary, indoor living.1 These same phenomena are contributing to the surging prevalence of obesity, metabolic syndrome, and diabetes. Early evidence suggests that vitamin D deficiency may contribute to diabetes, and that vitamin D repletion may ameliorate abnormal glucose homeostasis. Low vitamin C is associated with an increased risk of the future development of diabetes. It is likely that low vitamin C is a marker of a less healthy lifestyle, a well-known risk factor for diabetes.
Vitamin C is an antioxidant, and the structural similarity between vitamin C and glucose makes it of interest in diabetes.2 Oxidative stress can lead to disturbed glucose metabolism and hyperglycemia.3 Therefore, a benefit of antioxidants to prevent diabetes or to achieve positive outcomes in type 2 diabetes mellitus (T2DM) is biologically plausible.
Vitamin D plays a vital role in whole-body calcium homeostasis by exerting classic effects on the duodenum, bone, and kidney.4,5 Vitamin D may also alter intracellular calcium signals and thus plays a role in pancreatic insulin secretion and insulin sensitivity, both of which relate to calcium levels. It therefore has potential in the prevention of T2DM. The role of vitamin D in insulin resistance has been studied extensively, and vitamin C is another vitamin for which studies have demonstrated significant associations with diabetes.6,7 This review explores the observational, interventional, and mechanistic studies that address the effects of vitamins C and D in T2DM.
Effects of vitamin C in diabetes
Physiology and vitamin C deficiency
Vitamin C, also known as ascorbic acid, is a cofactor in multiple enzymatic reactions including collagen synthesis.8 Humans are unable to produce vitamin C due to the absence of the enzyme, L-gulonolactone oxidase, which catalyzes the final step in the synthesis of ascorbic acid;9 therefore, it is an essential nutrient in humans. Vitamin C acts as a reducing agent in free radical-mediated oxidation processes; therefore, it can act as an antioxidant.9 Deficiency of vitamin C results in the defective formation of collagen and connective tissues in the skin, cartilage, dentine, bone, and blood vessels.
In its most severe form, vitamin C deficiency results in scurvy, which is uncommon in developed nations due to the inclusion of fresh fruits and vegetables in the diet.1 Nevertheless, lesser degrees of vitamin C deficiency were found to be common among healthy adults in the United States (National Health and Nutrition Examination Survey [NHANES] 2003–2004: 7.1%).10 Smokers and people in lower-income groups were at increased risk of deficiency. Other classic risk factors include alcoholism and renal failure.
Though diabetes is not traditionally considered a risk factor for vitamin C deficiency, patients with diabetes should all receive dietary advice about healthy eating and vitamin C dietary sources, including fresh fruits and vegetables. The recommended dietary intake of vitamin C is 45 mg per day for adults.1 There are some data suggesting that people with diabetes may have increased cellular uptake and turnover of vitamin C that would necessitate increased intake, and they also have an increased risk of deficiency.11
The effects of vitamin C in diabetes have been an area of interest for over 50 years. A review of 23 observational studies looking at the vitamin C status of people with diabetes published between 1935 and 1996 found that people with diabetes have at least 30% lower vitamin C concentrations than do people without diabetes.11 However, there was heterogeneity among the studies in terms of the methods used to measure vitamin C status, and subjects were unmatched on important covariates such as dietary intake of vitamin C, sex, smoking status, and acute illness.
Observational data from NHANES 1988–1994 identified that people with newly diagnosed diabetes had significantly lower serum vitamin C concentrations than did people without diabetes; however, no difference was seen after adjusting for the dietary intake of vitamin C.6 On the other hand, among those with a similar dietary intake of vitamin C, those with diabetes of 2 months to 25 years’ duration did have lower levels of vitamin C when compared to controls.6,12,13 In the Finnish Mobile Clinic Health Examination Survey conducted during 1966–1972, the association between low vitamin C levels and diabetes was also not demonstrated to be due to low dietary vitamin C.14 This prospective study estimated total habitual food consumption in the previous year, and it examined the incidence of diabetes during a 23-year follow-up period. About 380 cases of diabetes were identified, but vitamin C intake was not associated with the risk of T2DM.
In a cross-sectional study where dietary vitamin C intake was the same, lower vitamin C levels in people with diabetes were seen as a consequence of diabetes itself and not due to the inadequate dietary intake of vitamin C.15 In a nested case-control study in Korea,16 there was no difference in dietary vitamin C intake between those with diabetes and controls matched for age, sex, drinking status, and smoking status. Interestingly, however, nonsmoking individuals with a new diagnosis of T2DM had lower serum vitamin C levels (22.3±16.8 μmol/L) than did controls (26.3±17.0 μmol/L) (P<0.01).16 Among smokers, there was no difference between serum vitamin C levels in those with diabetes and controls. Therefore, smoking – a known trigger of vitamin C deficiency – appears to modify the association between vitamin C and diabetes incidence.
An English population-based prospective cohort study of 25,639 volunteer participants demonstrated a strong inverse association between plasma vitamin C levels and incident diabetes after 8–12 years with a dose–response effect.17 A 29% reduction was found in diabetes risk per 19.87 μmol/L (0.35 mg/dL) change in vitamin C level, which was adjusted for important covariates including the use of vitamin supplements. However, vitamin C may actually be a marker of other protective factors found in fruits and vegetables that may decrease the risk of T2DM.18
An association between vitamin C levels and glycemic control was assessed in a cross-sectional study of people with diabetes, which identified a weak, negative correlation between hemoglobin A1c (HbA1c) and vitamin C levels.19 The relationship between vitamin C and glucose levels was also demonstrated in a large sample of US adults without a history of diabetes from NHANES 2003–2006, in which serum vitamin C concentrations were inversely associated with HbA1c levels.20 An observational study on the use of vitamin C supplements demonstrated that a significantly lower risk of diabetes was associated with the use of daily vitamin C supplements when compared to nonusage.21 The potential benefit of a vitamin C supplement was limited to those who did not take a multivitamin or those who had a lower dietary intake of vitamin C. However, the observational nature could not demonstrate a cause-and-effect relation, nor could confounding be excluded, such as health-conscious users of supplements being less likely to develop disease. To rectify this, a post hoc analysis from the SU.VI.MAX study,22 a randomized trial to assess the effects of a combination of vitamins and minerals including vitamin C, was performed. Plasma concentrations of vitamin C were inversely (P=0.046) associated with fasting plasma glucose levels; however, over the follow-up period of 7.5 years, supplementation had no effect on age-adjusted fasting plasma glucose levels.
Observational studies have suggested that people with T2DM have lower vitamin C levels, and this was not explained by differences in dietary vitamin C intake when compared to people without diabetes. There may be an association between lower vitamin C levels and the subsequent development of diabetes, as well as higher glucose levels.
In three intervention studies of vitamin C supplementation in T2DM, an improvement was seen in fasting glucose and HbA1c levels, but only with a higher dose supplementation of 2,000 mg of vitamin C per day for 90 days, with no improvement observed after 2 months of 500 mg daily vitamin C supplementation, nor with short-term supplementation over 2 weeks.23–25 This finding may be due to an inadequate increase in vitamin C levels in diabetes with standard supplementation doses or of brief duration. The difficulty with interpreting the vitamin C intervention studies is the use of study populations with adequate vitamin C levels, which significantly decreases the likelihood of observing any effects of the intervention.26,27 Another randomized controlled trial28 demonstrated that supplementation with 800 mg per day for 4 weeks in people with T2DM and low plasma vitamin C levels (<40 μmol/L) at baseline was insufficient for replenishing serum levels to what is seen in healthy subjects (>80 μmol/L). The lower vitamin C levels achieved could have explained the lack of improvement in measures of insulin resistance in the supplemented group.
The addition of vitamin C supplementation to standard therapy was assessed in 70 patients treated with metformin for T2DM who were randomized to 500 mg twice daily of vitamin C or placebo for 12 weeks.29 Those given vitamin C were identified to have lower HbA1c, fasting, and postmeal blood glucose levels when compared to the placebo group, despite all being treated with metformin.
Apart from the impact on glycemic control, antioxidant supplementation has been studied for the prevention of complications of diabetes. An improvement in neuropathic symptoms (but not in objective signs of neuropathy) and decreased odds of retinopathy were seen with the use of a combination of vitamin supplements including vitamin C.30,31 The impact of high dietary vitamin C and supplementation has been demonstrated to have variable effects on cardiovascular complications in diabetes.32,33
Interventional studies with vitamin C supplements have not consistently demonstrated improvements in glycemic control in T2DM. Vitamin C as an antioxidant could reduce the risk of complications of T2DM; however, excess supplementation may increase the risk of cardiovascular disease.32
The significance of vitamin C in T2DM has been suggested by the hypothesis that hyperglycemia inhibits the cellular uptake of dehydroascorbic acid (DHA), which is the oxidized transportable form of vitamin C.34,35 In the red blood cell, glucose strongly inhibits the uptake of DHA; therefore, hyperglycemia in diabetes would be expected to cause vitamin C deficiency within the cell.35 DHA uptake into the cells is accomplished through glucose transporters, GLUT1 and GLUT3, which transport DHA in competition with glucose,36,37 and this effect may be overcome by a large intake of vitamin C.38
The mechanisms for reduced vitamin C levels in diabetes are suggested by animal studies. A study of rats with streptozotocin-induced diabetes39 demonstrated a decrease in serum levels of vitamin C and the increased urinary excretion of vitamin C when compared to the levels obtained prior to the induction of diabetes in the same rats, suggesting that the renal reabsorption of vitamin C is reduced in diabetes. Another study of diabetic rats12 demonstrated an increased turnover of vitamin C, and this finding was most likely due to the increased oxidation of ascorbate to DHA in tissue mitochondria. Furthermore, a human study of vitamin C turnover, measured by the rate of reduction of DHA to ascorbic acid, indicated that this turnover was higher in a group of people with diabetes than in volunteers without diabetes.12 This higher turnover of vitamin C in diabetes may underlie the need for higher dietary vitamin C requirements in diabetes.
Significant benefits of vitamin C supplementation have been demonstrated in an animal model of T2DM. Vitamin C supplementation in ob/ob mice caused significant reductions in food intake, plasma glucose, HbA1c levels, plasma glucose levels, and insulin concentrations when compared with untreated control ob/ob mice.40 The total insulin content and the extent of insulin glycation in the pancreas of ob/ob mice also decreased after vitamin C supplementation. These parameters did not change with vitamin C supplementation in lean mice.
The biological mechanisms underlying lower vitamin C levels in people with diabetes includes decreased cellular uptake, increased urinary losses, and increased metabolic turnover of vitamin C in diabetes. These mechanisms suggest higher dietary vitamin C requirements in diabetes, along with the benefits of supplementation, as seen in a mouse model of T2DM.
Effects of vitamin D in diabetes
Vitamin D physiology
The name “vitamin D” is a historical misnomer because a vitamin, by definition, is something that we cannot synthesize ourselves. The active form of vitamin D, calcitriol, is synthesized in humans, and is a hormone that undergoes autocrine regulation. Vitamin D is synthesized from cholesterol precursors. Moreover, 7-dehydrocholesterol is converted to vitamin D in the skin following exposure to ultraviolet radiation. This molecule binds to vitamin D-binding protein (DBP) and undergoes hydroxylation in two stages: firstly, in the liver to form 25-OH vitamin D (25OHD); and secondly, in the kidney to form 1,25(OH)2vitamin D (1,25[OH]2D). In its active form, vitamin D (1,25[OH]2D) has predominant effects in calcium and mineral homeostasis by interacting with the vitamin D receptor (VDR).4 The VDR is present in tissues involved in calcium/phosphate homeostasis (ie, the intestine, bone, kidney), and it is present at lower levels in other tissues, suggesting the nonclassical roles of vitamin D (eg, in glucose homeostasis).
The potential effects of vitamin D on insulin sensitivity and glucose tolerance have been the subject of a recent review.5 In 808 subjects without diabetes, plasma 25OHD correlated inversely with fasting insulin levels and Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) scores after adjusting for sex, age, and body mass index (BMI).41 A similar link between HOMA-IR and 25OHD was found in 712 prediabetic subjects.42 HOMA used data from physiological studies to derive equations to assess insulin resistance (HOMA-IR) and insulin sensitivity (HOMA-S) from matched fasting insulin and glucose samples.43 In an elegant study of healthy adults,44 there was a significant association between 25OHD and insulin sensitivity assessed by hyperglycemic clamps, after adjusting for BMI and a range of other factors.
Prospective studies have demonstrated that 25OHD levels correlate with the long-term risk of insulin resistance. In a study of 5,200 participants, a 25 nmol/L increment in baseline serum 25OHD levels correlated with a 24% reduced risk of developing diabetes over 5 years, although this was a nonlinear relation.45 Furthermore, a meta-analysis of 21 prospective studies identified a linear trend for each 10 nmol/L increment in 25OHD levels to be associated with a 4% lower risk of T2DM (95% confidence interval [CI]: 3–6; P for a linear trend, <0.0001).46 An independent association with HOMA-S at 5 years was also found (r=0.16; P<0.001). Furthermore, vitamin D status and T2DM were inversely associated in multiple observational studies.46–52
In the Women’s Health Study,53 dietary vitamin D was inversely associated with metabolic syndrome, but this was related to total calcium intake. The Nurses’ Health Study48 showed that there was a decrease in the relative risk of incident diabetes of 0.87 (95% CI: 0.75–1.00; P for trend =0.04) among those on high-dose vitamin D supplements (>800 IU daily), as compared to those on low-dose vitamin D supplements (<400 IU daily); this was also seen with calcium intake.
Studies have demonstrated an association between vitamin D and insulin resistance, which is significant for the risk of developing T2DM. Although suggestive, these observational studies do not prove a causal relationship between vitamin D and insulin resistance. A number of factors may confound this link, such as adiposity.54 Obese individuals may avoid sun exposure, and vitamin D (a lipophilic compound) may be trapped in adipose tissue, resulting in serum deficiency. Obesity is also a major determinant of insulin resistance. Other confounders include parathyroid hormone levels,55 calcium levels, physical activity, and diet. These may influence vitamin D and independently alter insulin sensitivity.
In the absence of insulin resistance, vitamin D supplementation does not alter insulin sensitivity.7,56–58 However, some evidence indicates that subjects with prediabetes may benefit. At-risk subjects receiving various regimens of vitamin D and calcium over 6 weeks to 3 years showed significant improvements in insulin secretion, sensitivity, and/or the disposition index (a marker of insulin secretion/activity).7,59–61
The evidence that vitamin D improves glycemic control in subjects with established diabetes is mixed. In a recent trial,62 90 subjects with diabetes were randomized to daily vitamin D (1,000 IU), taken in fortified yogurt; these subjects showed better glycemic control and reduced insulin resistance (HOMA-IR) when compared to subjects on plain yogurt. Importantly, serum vitamin D levels and HOMA-IR scores correlated inversely in this study. Another three studies of vitamin D supplementation of 3 weeks to 3 months’ duration have demonstrated positive effects on HbA1c levels, insulin resistance, and insulin secretion compared to placebo, while other studies have shown no benefit from brief supplementation with low doses of vitamin D, nor with high doses of over 6 months’ duration.63–67
Small interventional studies examining different populations with variable vitamin D levels, using different regimens of supplementation, make it difficult to draw definite conclusions. Parameters of insulin sensitivity are variable, ranging from measuring fasting insulin to hyperinsulinemic–euglycemic clamps. While insulin resistance leads to diabetes, a complex interaction between glucose and insulin levels exists. Glycemic outcomes reflect the interplay between insulin resistance and insulin secretion by pancreatic beta-cells.
Therefore, whether vitamin D supplementation results in clear improvement in diabetes remains unclear. A randomized controlled trial of two doses of vitamin D supplementation (5,000 IU versus 400 IU daily) did not demonstrate improved glucose levels in pregnancy, despite another study showing a link between vitamin D levels and the subsequent risk of gestational diabetes.68,69 Large trials are currently underway in other populations, which may definitively resolve this question (eg, NCT01354964, NCT01315366, NCT00736632, and Pittas et al70).
Mouse models of diabetes demonstrate improvements in insulin sensitivity following the administration of 1αOHD3.4 This vitamin D analog is automatically 25-hydroxylated in the liver, forming calcitriol, and it bypasses normal endocrine regulation of the activation process. An in vitro study has shown that 1,25(OH)2D increases insulin receptor expression and insulin signaling via Akt and insulin receptor phosphorylation.71 Nongenomic, rapid effects of vitamin D may also play a role. Apart from calcium regulation, vitamin D leads to the release of arachidonic acid, a polyunsaturated fatty acid, from the cell membrane and into the muscle cell cytoplasm.72 This links vitamin D with insulin sensitivity, as does the possibility that vitamin D may modulate caveolin-I,73 a scaffolding protein within the membrane that exerts its effects in metabolism.
Pancreatic beta-cells, responsible for insulin secretion, express components of the vitamin D pathway, including 1α-hydroxylase enzyme, a vitamin D-dependent calcium-binding protein (calbindin), and the VDR.74 Vitamin D treatment increases insulin secretion in vitamin D-deficient rodents and cultured pancreatic cells. This effect occurs via intracellular calcium signals and altered gene expression, but its physiological significance is unclear. Animal models and in vitro studies provide potential mechanisms for the associations between vitamin D and insulin resistance.
- Observational studies indicate a link between deficiencies in vitamins C and D and the prevalence of type 2 diabetes.
- There is biological plausibility for the effects of vitamins C and D in glucose homeostasis. Vitamin C prevents oxidative stress and is known to interact with glucose transporters, potential mechanisms by which it may also alter glucose homeostasis. Vitamin D may affect calcium handling in pancreatic beta-cells and skeletal muscle, thereby affecting insulin secretion and sensitivity, respectively.
- Randomized controlled trials have not clearly demonstrated the effects of vitamins C and D in the prevention or treatment of diabetes. This is due to a range of factors, including heterogeneity in study design and endpoints, and the lack of standardized supplementation regimens. Further research will address the impact of these nutrients in glucose homeostasis.
The relationship between diabetes and vitamins C and D have been demonstrated by human and animal studies. The limitation of observational studies is that confounders cannot be excluded to explain the relationship between vitamin deficiency and diabetes outcomes. Interventional studies that are randomized provide the best evidence for a benefit of supplementation, with serum vitamin levels indicating variations in the dietary intake of vitamin C and the levels of sun exposure for vitamin D. Animal models can provide an indication of the mechanisms that underlie these associations; however, metabolic processes in animals are not directly translated in humans.
Vitamin C levels are lower among people with T2DM and not completely explained by a difference in dietary vitamin C intake. A number of mechanisms underlying the decrease in vitamin C levels and increased requirements in T2DM have been proposed.75 Consequently, the dietary requirements or the need for supplementation of vitamin C may be greater in people with diabetes. However, studies of vitamin C supplements alone or in combination have not demonstrated sufficient benefit to support a recommendation for routine supplementation, nor higher target serum vitamin C levels, in people with T2DM. Further studies are needed to determine if vitamin C supplementation may play a role in minimizing the risk of complications of diabetes.
While strong links between vitamin D and diabetes have been demonstrated, it remains to be determined whether this is by cause or association. Increasing endogenous levels of vitamins C and D can be achieved by dietary modifications, and in the case of vitamin D, also by judicious sun exposure.76 The availability of supplements enables a convenient method of reaching a prespecified serum vitamin C and D level. However, as with many other nutrients, the maximum health benefit is probably obtained by achieving the recommended daily intake of vitamin C as part of a balanced diet, and maintaining vitamin D status by regular sun exposure. Further studies – in particular, randomized controlled trials – are needed to determine if there is a benefit of routine supplementation with these vitamins in diabetes or for its prevention.
CMG received salary support from postgraduate scholar awards (Australian Postgraduate Award) from the University of Sydney and the Joseph Thornton Tweddle Research Scholarship 2014 (Royal Australasian College of Physicians). JEG is supported by the National Health and Medical Research Council.
The authors report no conflicts of interest in this work.
Nutrient Reference Values for Australia and New Zealand Including Recommended Dietary Intakes. NHMRC Guidelines. 2005;Sept:119–125. Available from: https://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/n35.pdf. Accessed December 30, 2014.
Mann GV. Hypothesis: the role of vitamin C in diabetic angiopathy. Perspect Biol Med. 1974;17(2):210–217.
Opara EC. Role of oxidative stress in the etiology of type 2 diabetes and the effect of antioxidant supplementation on glycemic control. J Investig Med. 2004;52(1):19–23.
Girgis CM, Clifton-Bligh RJ, Hamrick MW, Holick MF, Gunton JE. The roles of vitamin D in skeletal muscle: form, function, and metabolism. Endocr Rev. 2013;34(1):33–83.
Girgis CM, Clifton-Bligh RJ, Turner N, Lau SL, Gunton JE. Effects of vitamin D in skeletal muscle: falls, strength, athletic performance and insulin sensitivity. Clin Endocrinol (Oxf). 2014;80(2):169–181.
Will JC, Ford ES, Bowman BA. Serum vitamin C concentrations and diabetes: findings from the Third National Health and Nutrition Examination Survey, 1988–1994. Am J Clin Nutr. 1999;70(1):49–52.
Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care. 2007;30(4):980–986.
Ronchetti IP, Quaglino D Jr, Bergamini G. Ascorbic acid and connective tissue. Subcell Biochem. 1996;25:249–264.
Mandl J, Szarka A, BÁnhegyi G. Vitamin C: update on physiology and pharmacology. Br J Pharmacol. 2009;157(7):1097–1110.
Schleicher RL, Carroll MD, Ford ES, Lacher DA. Serum vitamin C and the prevalence of vitamin C deficiency in the United States: 2003–2004 National Health and Nutrition Examination Survey (NHANES). Am J Clin Nutr. 2009;90(5):1252–1263.
Will JC, Byers T. Does diabetes mellitus increase the requirement for vitamin C? Nutr Rev. 1996;54(7):193–202.
Som S, Basu S, Mukherjee D, et al. Ascorbic acid metabolism in diabetes mellitus. Metabolism. 1981;30(6):572–577.
Sundaram RK, Bhaskar A, Vijayalingam S, Viswanathan M, Mohan R, Shanmugasundaram KR. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin Sci (Lond). 1996;90(4):255–260.
Montonen J, Knekt P, Järvinen R, Reunanen A. Dietary antioxidant intake and risk of type 2 diabetes. Diabetes Care. 2004;27(2):362–366.
Sinclair AJ, Taylor PB, Lunec J, Girling AJ, Barnett AH. Low plasma ascorbate levels in patients with type 2 diabetes mellitus consuming adequate dietary vitamin C. Diabet Med. 1994;11(9):893–898.
Shim JE, Paik HY, Shin CS, Park KS, Lee HK. Vitamin C nutriture in newly diagnosed diabetes. J Nutr Sci Vitaminol (Tokyo). 2010;56(4):217–221.
Harding AH, Wareham NJ, Bingham SA, et al. Plasma vitamin C level, fruit and vegetable consumption, and the risk of new-onset type 2 diabetes mellitus: the European prospective investigation of cancer – Norfolk prospective study. Arch Intern Med. 2008;168(14):1493–1499.
Hercberg S, Czernichow S, Galan P. Vitamin C concentration and type 2 diabetes mellitus. Arch Intern Med. 2009;169(6):634.
Lysy J, Zimmerman J. Ascorbic acid status in diabetes mellitus. Nutrition Research. 1992;12(6):713–720.
Kositsawat J, Freeman VL. Vitamin C and A1c relationship in the National Health and Nutrition Examination Survey (NHANES) 2003–2006. J Am Coll Nutr. 2011;30(6):477–483.
Song Y, Xu Q, Park Y, Hollenbeck A, Schatzkin A, Chen H. Multivitamins, individual vitamin and mineral supplements, and risk of diabetes among older US adults. Diabetes Care. 2011;34(1):108–114.
Czernichow S, Couthouis A, Bertrais S, et al. Antioxidant supplementation does not affect fasting plasma glucose in the Supplementation with Antioxidant Vitamins and Minerals (SU.VI.MAX) study in France: association with dietary intake and plasma concentrations. Am J Clin Nutr. 2006;84(2):395–399.
Bishop N, Schorah CJ, Wales JK. The effect of vitamin C supplementation on diabetic hyperlipidaemia: a double blind, crossover study. Diabet Med. 1985;2(2):121–124.
Eriksson J, Kohvakka A. Magnesium and ascorbic acid supplementation in diabetes mellitus. Ann Nutr Metab. 1995;39(4):217–223.
Lu Q, Björkhem I, Wretlind B, Diczfalusy U, Henriksson P, Freyschuss A. Effect of ascorbic acid on microcirculation in patients with Type II diabetes: a randomized placebo-controlled cross-over study. Clin Sci (Lond). 2005;108(6):507–513.
Carr AC, Vissers MC. Synthetic or food-derived vitamin C – are they equally bioavailable? Nutrients. 2013;5(11):4284–4304.
Heaney RP. Guidelines for optimizing design and analysis of clinical studies of nutrient effects. Nutr Rev. 2014;72(1):48–54.
Chen H, Karne RJ, Hall G, et al. High-dose oral vitamin C partially replenishes vitamin C levels in patients with Type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance. Am J Physiol Heart Circ Physiol. 2006;290(1):H137–H145.
Dakhale GN, Chaudhari HV, Shrivastava M. Supplementation of vitamin C reduces blood glucose and improves glycosylated hemoglobin in type 2 diabetes mellitus: a randomized, double-blind study. Adv Pharmacol Sci. 2011;2011:195271.
Farvid MS, Homayouni F, Amiri Z, Adelmanesh F. Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation. Diabetes Res Clin Pract. 2011;93(1):86–94.
Millen AE, Klein R, Folsom AR, Stevens J, Palta M, Mares JA. Relation between intake of vitamins C and E and risk of diabetic retinopathy in the Atherosclerosis Risk in Communities Study. Am J Clin Nutr. 2004;79(5):865–873.
Ye Z, Song H. Antioxidant vitamins intake and the risk of coronary heart disease: meta-analysis of cohort studies. Eur J Cardiovasc Prev Rehabil. 2008;15(1):26–34.
Lee DH, Folsom AR, Harnack L, Halliwell B, Jacobs DR Jr. Does supplemental vitamin C increase cardiovascular disease risk in women with diabetes? Am J Clin Nutr. 2004;80(5):1194–1200.
Stankova L, Riddle M, Larned J, et al. Plasma ascorbate concentrations and blood cell dehydroascorbate transport in patients with diabetes mellitus. Metabolism. 1984;33(4):347–353.
Mann GV, Newton P. The membrane transport of ascorbic acid. Ann N Y Acad Sci. 1975;258:243–252.
Rumsey SC, Kwon O, Xu GW, Burant CF, Simpson I, Levine M. Glucose transporter isoforms GLUT1 and GLUT3 transport dehydroascorbic acid. J Biol Chem. 1997;272(30):18982–18989.
Vera JC, Rivas CI, Fischbarg J, Golde DW. Mammalian facilitative hexose transporters mediate the transport of dehydroascorbic acid. Nature. 1993;364(6432):79–82.
Verlangieri AJ, Sestito J. Effect of insulin on ascorbic acid uptake by heart endothelial cells: possible relationship to retinal atherogenesis. Life Sci. 1981;29(1):5–9.
Zebrowski EJ, Bhatnagar PK. Urinary excretion pattern of ascorbic acid in streptozotocin diabetic and insulin treated rats. Pharmacol Res Commun. 1979;11(2):95–103.
Abdel-Wahab YH, O’Harte FP, Mooney MH, Barnett CR, Flatt PR. Vitamin C supplementation decreases insulin glycation and improves glucose homeostasis in obese hyperglycemic (ob/ob) mice. Metabolism. 2002;51(4):514–517.
Liu E, Meigs JB, Pittas AG, et al. Plasma 25-hydroxyvitamin d is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr. 2009;139(2):329–334.
Kayaniyil S, Vieth R, Retnakaran R, et al. Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care. 2010;33(6):1379–1381.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–419.
Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004;79(5):820–825.
Gagnon C, Lu ZX, Magliano DJ, et al. Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle study). Diabetes Care. 2011;34(5):1133–1138.
Song Y, Wang L, Pittas AG, et al. Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care. 2013;36(5):1422–1428.
Mattila C, Knekt P, Männistö S, et al. Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care. 2007;30(10):2569–2570.
Pittas AG, Dawson-Hughes B, Li T, et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care. 2006;29(3):650–656.
Scragg R, Sowers M, Bell C; Third National Health and Nutrition Examination Survey. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care. 2004;27(12):2813–2818.
Isaia G, Giorgino R, Adami S. High prevalence of hypovitaminosis D in female type 2 diabetic population. Diabetes Care. 2001;24(8):1496.
Scragg R, Holdaway I, Singh V, Metcalf P, Baker J, Dryson E. Serum 25-hydroxyvitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus. Diabetes Res Clin Pract. 1995;27(3):181–188.
Pietschmann P, Schernthaner G, Woloszczuk W. Serum osteocalcin levels in diabetes mellitus: analysis of the type of diabetes and microvascular complications. Diabetologia. 1988;31(12):892–895.
Liu S, Song Y, Ford ES, Manson JE, Buring JE, Ridker PM. Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older US women. Diabetes Care. 2005;28(12):2926–2932.
Manco M, Calvani M, Nanni G, et al. Low 25-hydroxyvitamin D does not affect insulin sensitivity in obesity after bariatric surgery. Obes Res. 2005;13(10):1692–1700.
Valcour A, Blocki F, Hawkins DM, Rao SD. Effects of age and serum 25-OH-vitamin D on serum parathyroid hormone levels. J Clin Endocrinol Metab. 2012;97(11):3989–3995.
Fliser D, Stefanski A, Franek E, Fode P, Gudarzi A, Ritz E. No effect of calcitriol on insulin-mediated glucose uptake in healthy subjects. Eur J Clin Invest. 1997;27(7):629–633.
de Boer IH, Tinker LF, Connelly S, et al; Women’s Health Initiative Investigators. Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women’s Health Initiative. Diabetes Care. 2008;31(4):701–707.
Nilas L, Christiansen C. Treatment with vitamin D or its analogues does not change body weight or blood glucose level in postmenopausal women. Int J Obes. 1984;8(5):407–411.
Mitri J, Dawson-Hughes B, Hu FB, Pittas AG. Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr. 2011;94(2):486–494.
Nagpal J, Pande JN, Bhartia A. A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med. 2009;26(1):19–27.
von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient – a randomised, placebo-controlled trial. Br J Nutr. 2010;103(4):549–555.
Nikooyeh B, Neyestani TR, Farvid M, et al. Daily consumption of vitamin D- or vitamin D + calcium-fortified yogurt drink improved glycemic control in patients with type 2 diabetes: a randomized clinical trial. Am J Clin Nutr. 2011;93(4):764–771.
Sabherwal S, Bravis V, Devendra D. Effect of oral vitamin D and calcium replacement on glycaemic control in South Asian patients with type 2 diabetes. Int J Clin Pract. 2010;64(8):1084–1089.
Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract. 2003;57(4):258–261.
Inomata S, Kadowaki S, Yamatani T, Fukase M, Fujita T. Effect of 1 alpha (OH)-vitamin D3 on insulin secretion in diabetes mellitus. Bone Miner. 1986;1(3):187–192.
Jorde R, Figenschau Y. Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. Eur J Nutr. 2009;48(6):349–354.
Orwoll E, Riddle M, Prince M. Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus. Am J Clin Nutr. 1994;59(5):1083–1087.
Yap C, Cheung NW, Gunton JE, et al. Vitamin D supplementation and the effects on glucose metabolism during pregnancy: a randomized controlled trial. Diabetes Care. 2014;37(7):1837–1844.
Lacroix M, Battista MC, Doyon M, et al. Lower vitamin D levels at first trimester are associated with higher risk of developing gestational diabetes mellitus. Acta Diabetol. 2014;51(4):609–616.
Pittas AG, Dawson-Hughes B, Sheehan PR, et al; D2d Research Group. Rationale and design of the vitamin d and type 2 diabetes (d2d) study: a diabetes prevention trial. Diabetes Care. 2014;37(12):3227–3234.
Zhou QG, Hou FF, Guo ZJ, Liang M, Wang GB, Zhang X. 1,25-Dihydroxyvitamin D improved the free fatty-acid-induced insulin resistance in cultured C2C12 cells. Diabetes Metab Res Rev. 2008;24(6):459–464.
de Boland AR, Boland RL. 1,25-Dihydroxyvitamin D-3 induces arachidonate mobilization in embryonic chick myoblasts. Biochim Biophys Acta. 1993;1179(1):98–104.
Huhtakangas JA, Olivera CJ, Bishop JE, Zanello LP, Norman AW. The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1 alpha,25(OH)2-vitamin D3 in vivo and in vitro. Mol Endocrinol. 2004;18(11):2660–2671.
Johnson JA, Grande JP, Roche PC, Kumar R. Immunohistochemical localization of the 1,25(OH)2D3 receptor and calbindin D28k in human and rat pancreas. Am J Physiol. 1994;267(3 Pt 1):E356–E360.
Cunningham JJ. The glucose/insulin system and vitamin C: implications in insulin-dependent diabetes mellitus. J Am Coll Nutr. 1998;17(2):105–108.
Kimlin MG, Lucas RM, Harrison SL, et al. The contributions of solar ultraviolet radiation exposure and other determinants to serum 25-hydroxyvitamin D concentrations in Australian adults: the AusD Study. Am J Epidemiol. 2014;179(7):864–874.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]